Your browser doesn't support javascript.
loading
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
Berner, Fiamma; Niederer, Rebekka; Luimstra, Jolien J; Pop, Oltin Tiberiu; Jochum, Ann-Kristin; Purde, Mette-Triin; Hasan Ali, Omar; Bomze, David; Bauer, Jens; Freudenmann, Lena Katharina; Marcu, Ana; Wolfschmitt, Eva-Maria; Haen, Sebastian; Gross, Thorben; Dubbelaar, Marissa Lisa; Abdou, Marie-Therese; Baumgaertner, Petra; Appenzeller, Christina; Cicin-Sain, Caroline; Lenz, Tobias; Speiser, Daniel E; Ludewig, Burkhard; Driessen, Christoph; Jörger, Markus; Früh, Martin; Jochum, Wolfram; Cozzio, Antonio; Rammensee, Hans-Georg; Walz, Juliane; Neefjes, Jacques; Flatz, Lukas.
Afiliação
  • Berner F; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Niederer R; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Luimstra JJ; Department of Dermatology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Pop OT; Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Jochum AK; Oncode Institute, Utrecht, The Netherlands.
  • Purde MT; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Hasan Ali O; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Bomze D; Institute of Pathology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Bauer J; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Freudenmann LK; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Marcu A; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada.
  • Wolfschmitt EM; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Haen S; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Gross T; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Dubbelaar ML; Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Abdou MT; Cluster of Excellence iFIT (EXC2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Baumgaertner P; Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Appenzeller C; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.
  • Cicin-Sain C; Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Lenz T; Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Speiser DE; Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Ludewig B; Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Driessen C; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Jörger M; Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Früh M; Cluster of Excellence iFIT (EXC2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Jochum W; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.
  • Cozzio A; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Rammensee HG; Department of Oncology, Ludwig Cancer Research, University of Lausanne, Switzerland.
  • Walz J; Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Neefjes J; Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Flatz L; Research Unit Evolutionary Immunogenomics, Department of Biology, University of Hamburg, Hamburg, Germany.
Oncoimmunology ; 10(1): 2006893, 2021.
Article em En | MEDLINE | ID: mdl-34858733
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article